Drug Type Prophylactic vaccine, mRNA vaccine |
Synonyms Coreg28v2 60mer mRNA Vaccine/eODGT8 60mer mRNA Vaccine, eOD-GT8 60mer mRNA Vaccine (mRNA-1644) + Core-g28v2 60mer mRNA Vaccine (mRNA-1644v2-Core) |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| HIV Infections | Phase 1 | United States | 12 Nov 2021 |





